towards a state of optimal health". Lifestyle change can be facilitated through a combination of efforts to increase awareness, change behaviour, and create environments that support good health practice" 17 . It may also be described as "activities directed toward increasing the level of well-being and actualizing the health potential of individuals, families, and communities and societies" 18 . Healthy lifestyle change has been advocated as an essential element in the chronic patient rehabilitation process 19 and was congruent with rehabilitation goals that aim to enhance quality of life through maintaining optimal social participation and health 15 . However, this approach has been poorly developed 20 for rehabilitation populations affected with chronic diseases 21, 22 .
One aspect of health promotion is the awareness of modifiable lifestyle risk factors. tobacco smoking, insufficient physical activity and poor nutrition are key risk factors not only for cardiovascular complications but also for other aspects of chronic neuromuscular disorders such as DM1.
the prevalence of unhealthy lifestyle risk factors is influenced by poverty and people further down the social ladder usually run at least twice the risk of serious illness and premature death as those near the top 23 . It is acknowledged that the poor social and economic status typically prevailing in DM1 is related to the severity of the disease 12 . More particularly, each additional 100 CtG repeats was found to increase the odds of relying on social assistance by about 35% and of having low social support by about 22% 12 . the chances of experiencing socioeconomic deprivation are loaded heavily against more affected patients with DM1. a small study concluded that people with neuromuscular disorders are at high-risk of developing chronic diseases resulting from obesity and a sedentary lifestyle 24 . However, a more exhaustive clinical picture of the prevalence of these health lifestyle risk factors among DM1 patients is needed. Four different clinical phenotypes are recognized in DM1 according to age of onset in conjunction with [CtG]n repeats: congenital, childhood, classic (adult) and mild (late-onset) 25 . the severity of the disease and its impacts on social participation vary greatly between these phenotypes 10 . Since the risk of poverty is related to the severity of the disease and socio-economic conditions of individuals influence their lifestyle risk factors, we anticipate that the prevalence of such lifestyle risk factors will vary among the DM1 phenotypes.
thus, the objectives of the study are: 1) to determine the prevalence of risk factors among individuals with DM1; 2) to compare the prevalence of risk factors among classic and mild phenotype. this will guide the development of more adapted and focussed health promotion interventions in the future.
METHODS

Participants
two-hundred (200) patients with DM1 were randomly selected as described elsewhere 12 from a subset of 416 DM1 individuals listed at the Neuromuscular Clinic (NMC) of the Centre de santé et des services sociaux de Jonquière (Quebec, Canada). Inclusion criteria were: age > 18 years, having a molecular confirmation of DM1 diagnosis and being able to provide informed consent. For the purpose of this study, subjects were classified as having the mild phenotype of the disease if they presented at least two or more of the three following criteria: 9 1) CtG < 200; 2) Muscular Impairment Rating Scale (MIRS) 26 
Data Collection
Demographics: Information was gathered regarding age, sex, annual familial income, and educational level. CtG repeat was determined using Southern blot analysis. 12 Lifestyle risk factors: a registered nurse administered in person the validated provincial public health survey for tobacco smoking, illicit drug use, alcohol consumption and physical inactivity 27, 28 . National guidelines were used for categorizing risk factors for alcohol consumption 29 . In addition, a list of reasons preventing them from exercising was administered only to patients who expressed a wish to exercise more (list developed by experienced physiotherapists).
Criteria of overweight and obesity were derived from body mass index (BMI) formulae and calculated from measured height and weight. the Canadian Guidelines for Body Weight Classification was used for categorizing obesity (BMI ≥ 30) and overweight (25 < BMI < 30) 30 .
Statistical Analysis
Demographic and clinical characteristics of DM1 patients are presented with the mean, standard deviation (SD) and range for continuous variables, and frequency and percentage for nominal and categorical variables. Comparisons between mild and classic phenotypes were performed with χ2 tests with the yate's correction for continuity for 2 X 2 tables and with the Student ttests for continuous variables. all statistical analyses were performed with the SPSS package (11.0, SPSS, Chicago, Ill).
RESULTS
Characteristics of participants
Patients with the mild phenotype were older than those with the classic phenotype (table 1). the economic status differs between patients with classic and mild phenotypes: despite no significant differences in education, those with the classic phenotype present a lower annual family income and a higher rate of reliance on social assistance.
Results showed that over 50% of DM1 patients are overweight or obese, 23.6% are regular smokers, and 76% are physically inactive (table 2) . Except for overweight and obesity, significant differences were observed between patients with classic and mild phenotypes for all the other lifestyle risk factors: those with the classic phenotype are more often regular smokers, consume illicit drugs more often and are less physically active.
the mean BMI of the total sample was 26.0 (standard deviation 5.7). although no difference between the BMI patients with classic and mild phenotypes was observed, analysis by gender showed that, among women with the classic phenotype, 44.8% presented excess weight as compared to 24.0% among those with the mild phenotype (p = 0.03). For men, the BMI was similar for patients with the classic and mild phenotypes (p = 0.82) with an excess weight in 54% of patients.
also it was found that a large proportion of inactive DM1 patients wished to perform more physical activities. From a predetermined list of reasons, physical problems, fatigue, lack of money and lack of nearby facilities were the most common reasons evoked for being physically inactive (table 3) . Most reasons for not doing physical activities are similar between the two phenotypes except for patients with the mild phenotype more often reporting lack of time as a reason and patients with the classic phenotype reporting more frequently lack of help as a reason. all 14 illicit drug users were cannabis consumers and one of them also reported LSD consumption during the last year. all of them had the classic phenotype. From the 158 participants with the classic phenotype, 5.1% are regular users (at least once a week) and 3.8% are occasional users (less than once a week). Self-reported excessive alcohol consumption was present in only seven participants. 
DISCUSSION
Lifestyle habits in DM1
Overweight and obesity. the proportion of DM1 patients with obesity (21%) is higher than in the regional reference population (Saguenay-Lac-St-Jean, Québec, Canada) (13.9%) 31 and the proportion of those who are overweight (32.5%) is slightly lower (36.0%) 31 . the present results are in accordance with previous observations that DM1 patients constitute a population which exercises less and has a higher fat and carbohydrate intake than the daily intake recommendation 32 . although patients with the classic phenotype exercise less than those with the mild phenotype, the proportion of DM1 patients with obesity or overweight conditions is similar for the two phenotypes. the comparison with the trend in the Canadian population is difficult to make as prevalence of obesity increases with age until 65 years and then tend to decrease. Considering that the mild phenotype has a mean age of 57 years, it could be explained by an age factor but other factors could come into play. In addition, the standard anthropometric measures such as BMI may have less clinical meaning in DM1 than in the general population. In cases of reduced muscular mass such as in the DM1 population, the BMI would tend to underestimate the prevalence of obesity and waist circumference could represent a better marker of abdominal fat accumulation 33 . However, as the abdominal muscles are weak in DM1, it is not clear if waist circumference would be a more reliable measure of obesity than BMI.
the prevention of obesity is particularly important in DM1 as almost all patients are affected at a certain level by a metabolic syndrome, including abnormalities in fat metabolism and body fat distribution, insulin resistance, elevated glucose and dyslipidemia (hypertriglyceridemia and low HDL-cholesterol levels) 14, 34 . Poor diet choice has been previously described in neuromuscular disorders 35 and may contribute to the high prevalence of overweight and obesity recorded in DM1. In the general population, the highest rates of obesity occur among population groups with the highest poverty rates. Poverty and food insecurity (limited or uncertain availability of nutritionally acceptable or safe foods) 36 are associated with lower food expenditures, low fruit and vegetable consumption, and lowerquality diets, where peoples tend to ingest inexpensive energydense foods (sugar and fat combination) 36 . this type of food is readily available as processed food, which may compensate for expressed difficulties (lower strength, planification, etc.) related to cooking tasks and is often cheaper than healthier food choices 37 . One study has explored a one-time dietary intervention followed by phone counselling once a week among neuromuscular patients including DM1; it has showed a modest but interesting effect over a 12 months period on caloric intake 37 . Tobacco smoking. the prevalence of tobacco smoking (30.1%) is higher in DM1 than that observed in the regional population (24.20%) 31 or in the province of Quebec population (25%). We found a significantly higher smoking rate among patients with the classic phenotype than among those with the mild phenotype. as in the general population 23 , it could partly be explained by the relationship between socioeconomic deprivation and higher rates of smoking and between age and smoking cessation, in the context that mild phenotype patients were older. Respiratory disorders (pneumonia, chronic respiratory failure) followed by cardiac disease are the leading causes of death in DM1 38 . Brief and intensive interventions to be administered by healthcare professionals are available from national anti-smoking agencies and should be integrated into the health care management plan for this population.
Physical inactivity. a majority of DM1 patients (76%) are physically inactive as compared to the reference population (47.9%) 31 . Patients with the classic phenotype are significantly less active than those with the mild phenotype, although the latter are older. Several personal and environmental factors reported by the patients explain this situation including physical problems, fatigue, lack of money, lack of nearby facilities and lack of help. Using the LIFE-H questionnaire 39 , we previously showed that 37.3% of the patients with the classic phenotype reported "needing help" or "not accomplishing activities" related to the practice of physical activities to maintain their fitness as compared to 1.0% in patients with the mild phenotype 10 . We also reported that more than one third of patients were highly dissatisfied regarding their participation in physical activities 10 . Other features specific to DM1 such as lack of motivation and daytime sleepiness may play a role 40 as well as living in a disadvantaged milieu where low practice of physical activities is usually observed. although several obstacles are present, potential benefits of physical activities should not be overlooked and should be promoted in the DM1 population. Exercise and aerobic capacity programs have been recommended in neuromuscular disorders in order to improve or preserve muscle function and to prevent or reduce secondary problems such as pain or fatigue [41] [42] [43] . In view of the prevalence of excessive weight, the practice of physical activities could also prevent further weight gain or even promote weight loss. according to a recent Cochrane review, patients with neuromuscular disorders should be advised that normal participation in moderate-intensity strength training appears not to be detrimental 44 .
Alcohol consumption and illicit drug use. Excessive alcohol consumption was reported by only 3.5% of DM1 patients while 8.9% of the reference population reported excessive alcohol consumption 45 . Illicit drug use was also marginal among our total sample (7%) and exclusively found among the classic phenotype. this rate is below that observed in the province of Quebec population (13%) 46 although socioeconomic deprivation has been shown to increase the risk of dependence on alcohol and drugs 23 .
Health promotion in DM1
Factors influencing adoption of healthy lifestyle habits in DM1. Many health and social characteristics of DM1 may interfere with health promotion behaviours. Common DM1 symptoms such as lower limbs weakness, fatigue, daytime sleepiness, pain, apathy, frontal cognitive deficits, lower intellectual functioning and some personality traits may represent barriers to commitment in health promoting behaviours. In addition, personal factors such as acceptance of the disease and self-efficacy may also influence the engagement in health-promoting behaviours 15 .
In the general population, unhealthy lifestyle habits are known to be more prevalent among populations demonstrating poor socioeconomic conditions 47 . Patients with DM1 frequently show poor academic achievement, high unemployment, low family income, and high reliance on social assistance 12 . Myotonic dystrophy type 1 was found to be six times more prevalent in disadvantaged neighbourhoods compared with advantaged ones 48 . Such a residential segregation contributes to social exclusion and isolation and individuals with less social and emotional support from others would be more likely to experience lower well-being, as well as higher depression rate, and greater levels of disability from chronic diseases.
the autosomal dominant mode of inheritance of DM1 also contributes to this concentration effect; many affected relatives live together in the same house. this familial aggregation as well as the residential segregation could play a role in the limitation of the promotion of education and the lack of support to adopt healthy lifestyle habits. yet, it is not clear whether socioeconomic factors contribute more to unhealthy lifestyle habits than the health impairments themselves; their respective roles are difficult to ascertain in DM1 as patients with a higher socioeconomic status are those with fewer symptoms. thus, rationale and concerns about developing health promotion interventions among this population should take into account all the aspects of the disease, including characteristic impairments and disabilities as well as its socioenvironmental factors.
Limits of the study
the results are indicative of the French Canadian population of Québec, but may not be generalizable to other populations. the results are also self-reported for the most part and may not reflect properly the actual situation due to social desirability or memory bias.
CONCLUSION
Myotonic dystrophy type 1 patients present several risk factors, namely greater tobacco smoking, physical inactivity and obesity and overweight. all healthcare professionals involved in the clinical services dedicated to DM1 patients must be aware of these risk factors in order to address more efficiently patients' concerns and to favour health promotion. However, the expected poor adherence to healthy lifestyle behaviours should gear research toward developing adequate education strategies taking into consideration the complexity of the disablement and the social environment of DM1 patients.
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